What is ustekinumab?

Ustekinumab(ustekinumab) is used to treat certain types of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. Ustekinumabhelps reduce the symptoms of these diseases but does not cure these inflammatory diseases. Wezlanais an interchangeable biosimilar to ustekinumab. In the EU, ustekinumab is approved for the treatment of moderate-to-severe plaque psoriasis in adults and children aged 6 years and older who are not treated with other systemic therapies. pan>(Systemic)Psoriasis treatment methods have improved, or other systemic methods cannot be used(Systemic)Psoriasis treatments such as cyclosporine, methotrexate or PUVA (psoralen UV LineA), Active psoriatic arthritis in adults, Moderately to severely active Crohn's disease in adults, and moderately to severely active ulcerative colitis in adults. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.